Clinical trials recruiting for Advanced Head and Neck Squamous Cell Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Bevacizumab | 1 |
| Capivasertib | 1 |
| Cetuximab | 1 |
| Docetaxel | 1 |
| Glutaminase-1 Inhibitor IACS-6274 | 1 |
| HMBD-001 | 1 |
| Immune checkpoint inhibitor | 1 |
| Paclitaxel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Oregon | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Related conditions
Trials recruiting for Advanced Head and Neck Squamous Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Head and Neck Squamous Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.